# Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China

> clinical trial · VERIFIED · 2026-08-04

Status: RECRUITING · Sponsor: AstraZeneca · Condition: Limited Stage Small-Cell Lung Cancer

- Company: AstraZeneca
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07161388

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.